Search
Oregon Clinical Trials
A listing of clinical trials in Oregon actively recruiting patient volunteers.
1285 - 1295 of 1295
Featured Trial
CMV Vaccine Trial For Young Women Ages 16-17
Recruiting
A Cytomegalovirus (CMV) Investigational Vaccine Clinical Trial for Healthy Women Age 16 to 17 years old. Compensation included.
Conditions:
Healthy Volunteers
Healthy
Featured Trial
Paid Clinical Studies Nationwide
Recruiting
Nationwide clinical trials offered in your area. Some trials offering up to several thousand dollars in compensation for participation.
Conditions:
Healthy
Healthy Volunteer Study
Featured Trial
Paid Vaccine Study For Teens
Recruiting
Vaccine study that aims to protect teens ages 12–17 against Epstein-Barr virus (EBV) and infectious mononucleosis (mono).
Conditions:
Healthy
Healthy Volunteer Study
Featured Trial
Adult Migraine Study
Recruiting
Migraine study for adults. You may be compensated up to $800 for your time and travel expenses.
Conditions:
Headache
Cluster Headache
Headache Disorders
Post-Traumatic Headache
Migraine
Menstrual Migraine
Classic Migraine
Migraine
With or Without Aura
* Compensation for time may be available
Clinical Utility of Pharmacogenomics of Psychotropic Medications
Recruiting
While the scientific understanding of pharmacogenomics is quickly accelerating, its translation to clinical decision-making (especially in psychiatric practice) has progressed more slowly. In an effort to begin to bridge this translational gap, genetic testing has been developed for various and commonly existing psychiatric disorders, such as major depression, schizophrenia, bipolar disorder, and pain syndromes to improve the safety of prescribing psychotropic medications for these disorders. Th... Read More
Gender:
All
Ages:
Between 18 years and 80 years
Locations: Mujeeb Uddin Shad, Salem, Oregon
Conditions: Psychiatric Disorders, Pain
Tech4Rest Trial With Team Truck Drivers
Recruiting
The current project is a safety and health intervention focused on sleep and fatigue among truck driver teams (pairs), where one driver sleeps in a moving vehicle while the other partner drives. This study is conducted within the Oregon Healthy Workforce Center (OHWC), a NIOSH Center of Excellence in Total Worker Health. We will evaluate engineering and behavioral interventions to improve sleep, reduce fatigue, and impact Total Worker Health. An enhanced cab intervention will alter whole body vi... Read More
Gender:
All
Ages:
21 years and above
Locations: Oregon Health and Science University, Portland, Oregon
Conditions: Sleep, Sleep Disturbance, Sleep Disorder, Shift Work, Health Knowledge, Attitudes, Practice, Health Behavior, Fatigue, Vibration; Exposure
Vascular Cardiotoxicity of Ponatinib
Recruiting
Pre-clinical studies suggest that the third generation tyrosine kinase inhibitor ponatinib can result in microvascular angiopathy and acceleration of atherosclerosis. This study is intended to examine for myocardial microvascular angiopathy and changes in carotid plaque in patients receiving ponatinib as part of their clinical care.
Gender:
All
Ages:
Between 18 years and 100 years
Locations: Oregon HSU, Portland, Oregon
Conditions: Cardiotoxicity
Parkinson's Foundation Quality Improvement Initiative
Recruiting
In a recent study it was found that neurologist care for Parkinson's provides a 20% reduction in nursing home placement, hip fracture, and death (Willis 2011). However, as the authors recognized, the investigators don't know what it is about expert care that delivers this benefit. The Parkinson's Foundation's Quality Improvement Initiative was designed to identify the components of great care that yield great outcomes. By capturing demographics, clinical interventions and outcomes over time from... Read More
Gender:
All
Ages:
All
Locations: Oregon Health and Science University Parkinson Center, Portland, Oregon +23 locations
Conditions: Parkinson's Disease
PoNS Clinical Experience Program (TBI)
Recruiting
- Brief Summary: Prospective, cohort, open-label study. The cohort consists of people who have a chronic balance dysfunction due to a mild to moderate traumatic brain injury (TBI). All participants will participate in a 14-week PoNS Treatment protocol - a combination of symptom specific physical exercises and repeated use of the PoNS device.
Subjects who meet the initial screening entrance criteria will be scheduled for a baseline assessment to evaluate balance and gait. Subjects will then begi... Read More
Gender:
All
Ages:
18 years and above
Locations: Oregon Health & Science University, Portland, Oregon
Conditions: Mild to Moderate Traumatic Brain Injury
Acute Management of Humeral Shaft Fractures: Sling vs. Splint
Recruiting
When people break their arm and arrive at Oregon Health and Science University's Emergency Department (OHSU ED), they are treated with a short-term means of immobilizing their broken arm. The two most common ways of stabilizing the broken parts of the arm are 1) with a plaster-based coaptation splint, or 2) with a soft cloth sling and swathe. These hold the arm steady until the patient can schedule an appointment with the OHSU Orthopaedic Trauma clinic where they will receive definitive evaluati... Read More
Gender:
All
Ages:
Between 18 years and 80 years
Locations: Oregon Health and Science University, Portland, Oregon
Conditions: Fracture of Shaft of Humerus
Cerebrotendinous Xanthomatosis (CTX) Prevalence Study
Recruiting
This is an observational, multicenter study to determine the prevalence of Cerebrotendinous Xanthomatosis (CTX) in patient populations diagnosed with early-onset idiopathic bilateral cataracts. Patients who are potentially eligible for study participation will be identified through a chart review of patients who were seen at each study site prior to that site's initiation, or by entering care at the site while the site is participating in the trial.
Gender:
All
Ages:
Between 2 years and 21 years
Locations: Orgegon Health & Science University, Portland, Oregon +44 locations
Conditions: Cerebrotendinous Xanthomatosis (CTX)
Effects of Deepure(Pu-erh Tea Extract) on Glycemic Control
Recruiting
This is a randomized, controlled, cross-over study on the effects of consumption of Deepure puerh tea extract (PTE) on glucose tolerance and metabolic markers.
Gender:
All
Ages:
Between 18 years and 70 years
Locations: NIS labs, Klamath Falls, Oregon
Conditions: Glucose Metabolism Disorders
Augmentation of Limb Perfusion With Contrast Ultrasound
Recruiting
Our laboratory has discovered that ultrasound (US) imaging together with clinically approved microbubble ultrasound contrast agents can augment limb tissue perfusion. These observations have been made in mice with and without peripheral artery disease (PAD), and also in humans where high power contrast enhanced ultrasound (CEU) was used to measure perfusion but was found also to augment perfusion by almost 2-fold. The latter human studies were performed with ultrasound protocols designed for per... Read More
Gender:
All
Ages:
Between 19 years and 99 years
Locations: OHSU, Portland, Oregon
Conditions: Peripheral Arterial Disease
Ischemic Memory Imaging With Myocardial Contrast Echocardiography
Recruiting
The overall aim of this study is to determine whether non-invasive imaging with myocardial contrast echocardiography using can provide information on the presence and spatial extent of recent myocardial ischemia by non-invasive echocardiographic imaging.
Gender:
All
Ages:
Between 19 years and 90 years
Locations: OHSU, Portland, Oregon
Conditions: Myocardial Ischemia
Contrast Ultrasound Assessment of Perfusion Changes After Peripheral Artery Revascularization
Recruiting
This study represents an important step to validate the use of contrast-enhanced ultrasound (CEU) as a clinical research tool that can be used as a biologic readout of new therapies for Peripheral Artery Disease (PAD), and as a clinically-reasonable method for assessing impact of revascularization. The primary aim is to establish that CEU limb perfusion imaging can be used to accurately assess therapeutic improvements in tissue perfusion that are linked to symptom improvement.
Gender:
All
Ages:
Between 19 years and 99 years
Locations: OHSU, Portland, Oregon
Conditions: Peripheral Artery Disease